Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining

Majd A. Al-Hamaly; Yelena Chernyavskaya; Jessica S. Blackburn

doi:10.3791/67059

Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using ...

JoVE Journal
Cancer Research

A subscription to JoVE is required to view this content. Sign in or start your free trial.

JoVE Journal Cancer Research

Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining

Full Text

1,490 Views

06:41 min

July 19, 2024

DOI: 10.3791/67059-v

Majd A. Al-Hamaly^1,2, Yelena Chernyavskaya³, Jessica S. Blackburn^2,3

¹Pharmacology and Nutritional Sciences,The University of Kentucky, ²Markey Cancer Center,The University of Kentucky, ³Department of Molecular and Cellular Biochemistry,The University of Kentucky

Overview

This study focuses on identifying quiescent leukemia stem cells in a zebrafish model of T-cell acute lymphoblastic leukemia. By utilizing cell proliferation staining, researchers can isolate dormant cells for further analysis, enhancing the understanding of cellular quiescence and its implications for cancer treatment.

Key Study Components

Area of Science

Neuroscience
Cell Biology
Cancer Research

Background

Leukemia stem cells contribute to disease maintenance and relapse.
These cells often exist in a quiescent state, allowing them to evade treatments.
Understanding quiescence can reveal vulnerabilities in leukemia stem cells.
The zebrafish model provides a unique platform for studying these cells.

Purpose of Study

To characterize quiescent leukemia stem cells.
To explore methods for targeting and eliminating these cells.
To improve patient outcomes through better understanding of cellular behavior.

Methods Used

Cell proliferation staining to identify quiescent cells.
Isolation of dormant cells for further interrogation.
Application of findings to in vivo drug screening.
Utilization of transcriptomic profiling and proteomics analysis.

Main Results

Successful identification of quiescent leukemia cells in zebrafish.
Insights into the role of quiescence in leukemia stem cell survival.
Potential for developing targeted therapies based on cellular behavior.
Establishment of a functional tool for studying self-renewal.

Conclusions

Cell proliferation staining is effective for isolating quiescent cells.
Understanding quiescence is crucial for targeting leukemia stem cells.
This research provides a foundation for future therapeutic strategies.

Frequently Asked Questions

What is the significance of quiescent leukemia stem cells?

Quiescent leukemia stem cells are crucial for disease maintenance and relapse, making them important targets for therapy.

How does the zebrafish model contribute to this research?

The zebrafish model allows for in vivo studies of leukemia stem cells, providing insights into their behavior and treatment responses.

What methods are used to identify quiescent cells?

Cell proliferation staining is used to identify and isolate quiescent cells based on their proliferation status.

What downstream applications can arise from this study?

The isolated quiescent cells can be used for drug screening, transcriptomic profiling, and proteomics analysis.

What are the potential implications of this research?

This research could lead to new therapeutic strategies targeting quiescent leukemia stem cells, improving patient outcomes.

We used cell proliferation staining to identify quiescent cells in the zebrafish T-acute lymphoblastic leukemia model. The stain is retained in non-dividing cells and reduced during cell proliferation, enabling the selection of dormant cells for further interrogation. This protocol provides a functional tool to study self-renewal in the context of cellular quiescence.

Leukemia stem cells are a rare subpopulation of cells within the leukemia that are responsible for long-term disease, maintenance, and relapse. Our goal is to better characterize these cells to find ways to target and eliminate them and improve patient outcomes. Cancer stem cells, including leukemia stem cells, exist in a state of quiescence or slow growth, which may enable them to escape anti-proliferative cancer treatments.

Understanding cellular quiescence will help identify potential vulnerabilities of leukemia stem cells and new ways to target them. Using this protocol, we can identify and isolate quiescent leukemia cells from a zebra fish model of T-cell acute lymphoblastic leukemia. Those cells can be used for downstream applications, such as in vivo drug screening, transcriptomic profiling, and proteomics analysis.

View the full transcript and gain access to thousands of scientific videos